Determination of lamivudine/didanosine/nevirapine in human serum using capillary zone electrophoresis

Journal of Capillary Electrophoresis and Microchip Technology

Volumn 7, Issue 5-6, 2002, Pages 103-106

  Fan, Bin ^a   Stewart, James T ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Capillary zone electrophoresis; Didanosine; Human serum; Lamivudine; Nevirapine

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; DILTIAZEM; LAMIVUDINE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CALIBRATION; CAPILLARY ELECTROPHORESIS; CAPILLARY ZONE ELECTROPHORESIS; CHEMICAL STRUCTURE; DRUG BLOOD LEVEL; DRUG DETERMINATION; HUMAN; PH; SERUM; BLOOD; ISOLATION AND PURIFICATION; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ANTI-HIV AGENTS; DIDANOSINE; ELECTROPHORESIS, CAPILLARY; HUMANS; LAMIVUDINE; NEVIRAPINE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0038825077     PISSN: 10795383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Carpenter CCJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzentein DA, Montaner JSG, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society - USA panel. JAMA 1997; 77:1962-9.
2. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, Emini EA, Chodakewitz JA. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997; 337:734-9.
3. Cavert W, Notermans WDW, Staskus K, Wietgrefe SW, Zupancic M, Gebhard K, Henry K, Zhang ZQ, Mills R, McDade H, Goudsmit J, Danner SA, Haase AT. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Sciences 1997; 276:960-4.
4. Molla A, Korneyeva M, Gao Q, Vasavanonda S, Schipper PJ, Mo HM, Markowitz M, Chernyavskiy T, Niu P. Lyons N, Hsu A, Granneman GR, Ho DD, Boucher CA, Leonard JM, Norbeck DW, Kempf DJ. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nat Med 1996; 2:760-6.
5. Stein DS, Fish DG, Bilello JA, Preston SL, Martineau GL, Drusano GL. A 24-week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir). AIDS 1996; 10:485-92.
6. Havlir D, Cheeseman SH, McLaughlin M, Murphy R, Erice A, Spector SA, Greenough TC, Sullivan JL, Hall D, Myers M, Lamson M, Richman DD. High-dose nevirapine - safety, pharmacokinetics, and antiviral effect in patients with human-immunodeficiency-virus infection. J Infect Dis 1995; 171:537-45.
7. Kakuda TN, Struble KA, Piscitelli SC. Protease inhibitors for the treatment of human immunodeficiency virus infection. Am J Health-Syst Pharm 1998; 55:233-54.
8. Ha HR, Follath F, Bloenhard Y, Krahenbul S. Determination of saquinavir in human plasma by high-performance liquid chromatography. J Chromatogr B 1997; 694:427-33.
9. Wu EY, Wilkinson JM, Naret DG, Daniels VL, Williams LJ, Khalil DA, Shetty BV. High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasma. J Chromatogr B 1997; 695:373-80.
10. Hoetelmans RMW, van Essenberg M, Profijt M, Meenhorst PL, Mulder JW, Beijnen JH. High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid and saliva. J Chromatogr B 1998; 705:119-26.
11. Jenkins MA, Guerin MD. Capillary electrophoresis as a clinical tool. J Chromatogr B 1996; 682:23-34.
12. Altria KD. Capillary electrophoresis guidebook. Totowa, NJ: Humana Press, 1996:265, chap 18.